⸺ Celvora
Tesamorelin
GHRH analogue studied for stimulation of growth hormone release, with research interest in visceral fat and metabolic markers.
Secure checkout. Free shipping on orders over £100.
Independently tested
COA on request
Fast dispatch
Order before 2pm
Research use only
Not for human consumption
⸺ Overview
About Tesamorelin
Tesamorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH).
⸺ Mechanism of Action
How it works
Tesamorelin binds the GHRH receptor on pituitary somatotrophs, increasing pulsatile growth hormone release.
⸺ Research
Areas of study
Visceral fat in preclinical models
Studies report reductions in visceral adipose tissue.
Growth-hormone axis
Research shows increased pulsatile GH release and elevated IGF-1.
Metabolic markers
Preclinical work has examined effects on lipid profiles.
⸺ Details
Specification
- CAS
- 218949-48-5
- Intended use
- Research use only.
- Storage
- Lyophilised: cool, dry, dark.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: 24 months.
- Handling
- Sterile technique.
You might also research
View all →
Retatrutide
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied for appetite control, energy expenditure and glucose balance.
Tirzepatide
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.